The Journal of Clinical Endocrinology & Metabolism Publishes Radius Health's Phase II Study Of The Investigational Drug Abaloparatide In Postmenopausal Women With Osteoporosis
November 24, 2014 at 08:22 AM EST
Radius Health, Inc. (Nasdaq: RDUS) announced today that results from a multi-center, multi-national, double-blind placebo controlled ...
